April 4 (UPI) --New research by the American College of Emergency Physicians highlights the expanded availability and use of intranasal medication as an effective option in emergencies. Often when ...
The FDA has approved intranasal etripamil (Cardamyst; Milestone Pharmaceuticals) for the acute treatment of paroxysmal supraventricular tachycardia (PSVT), making it the first self-administered, ...
Self‐administration of investigational intranasal spray may be a new option to treat rapid heartbeat
A fast-acting medication delivered as a nasal spray may someday allow patients with intermittent rapid heartbeats to treat it themselves as soon as they develop symptoms, according to new research ...
--ONZETRA Xsail is the first breath-powered intranasal medication delivery system for the acute treatment of migraine-- ALISO VIEJO, Calif., January 28, 2016 -- Avanir Pharmaceuticals, Inc. today ...
A recent study published in Pathogens reported that an intranasal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine induced mucosal immune responses in mice. Study: Intranasal ...
The team developed a magnetically powered human nuclear transfer stem cells(hNTSC)-based microrobot and a method of minimally invasive delivery of therapeutic agents ...
--ONZETRA Xsail is the first breath-powered intranasal medication delivery system for the acute treatment of migraine-- ALISO VIEJO, Calif., January 28, 2016 -- Avanir Pharmaceuticals, Inc. today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback